nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Blood creatinine increased—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Meropenem—Gastrointestinal disorder—Vincristine—sarcoma	0.00143	0.00143	CcSEcCtD
Meropenem—Dyspepsia—Mitoxantrone—sarcoma	0.00142	0.00142	CcSEcCtD
Meropenem—Hypertension—Etoposide—sarcoma	0.00142	0.00142	CcSEcCtD
Meropenem—Constipation—Vincristine—sarcoma	0.00141	0.00141	CcSEcCtD
Meropenem—Pain—Vincristine—sarcoma	0.00141	0.00141	CcSEcCtD
Meropenem—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Meropenem—Decreased appetite—Mitoxantrone—sarcoma	0.0014	0.0014	CcSEcCtD
Meropenem—Chest pain—Etoposide—sarcoma	0.0014	0.0014	CcSEcCtD
Meropenem—Hypokalaemia—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00139	0.00139	CcSEcCtD
Meropenem—Pain—Mitoxantrone—sarcoma	0.00138	0.00138	CcSEcCtD
Meropenem—Constipation—Mitoxantrone—sarcoma	0.00138	0.00138	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Meropenem—Hypersensitivity—Thiotepa—sarcoma	0.00137	0.00137	CcSEcCtD
Meropenem—Hypersensitivity—Dactinomycin—sarcoma	0.00136	0.00136	CcSEcCtD
Meropenem—Gastrointestinal pain—Vincristine—sarcoma	0.00135	0.00135	CcSEcCtD
Meropenem—Confusional state—Etoposide—sarcoma	0.00135	0.00135	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Meropenem—Cardiac arrest—Doxorubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Meropenem—Anaphylactic shock—Etoposide—sarcoma	0.00134	0.00134	CcSEcCtD
Meropenem—Asthenia—Thiotepa—sarcoma	0.00134	0.00134	CcSEcCtD
Meropenem—Infection—Etoposide—sarcoma	0.00133	0.00133	CcSEcCtD
Meropenem—Abdominal distension—Epirubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Meropenem—Asthenia—Dactinomycin—sarcoma	0.00133	0.00133	CcSEcCtD
Meropenem—Feeling abnormal—Mitoxantrone—sarcoma	0.00133	0.00133	CcSEcCtD
Meropenem—Blood creatinine increased—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Meropenem—Asthma—Epirubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Meropenem—Pruritus—Thiotepa—sarcoma	0.00132	0.00132	CcSEcCtD
Meropenem—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00132	0.00132	CcSEcCtD
Meropenem—Thrombocytopenia—Etoposide—sarcoma	0.00131	0.00131	CcSEcCtD
Meropenem—Tachycardia—Etoposide—sarcoma	0.00131	0.00131	CcSEcCtD
Meropenem—Eosinophilia—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Meropenem—Abdominal pain—Vincristine—sarcoma	0.00131	0.00131	CcSEcCtD
Meropenem—Body temperature increased—Vincristine—sarcoma	0.00131	0.00131	CcSEcCtD
Meropenem—Skin disorder—Etoposide—sarcoma	0.0013	0.0013	CcSEcCtD
Meropenem—Hyperhidrosis—Etoposide—sarcoma	0.00129	0.00129	CcSEcCtD
Meropenem—Hypokalaemia—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Meropenem—Urticaria—Mitoxantrone—sarcoma	0.00128	0.00128	CcSEcCtD
Meropenem—Anorexia—Etoposide—sarcoma	0.00128	0.00128	CcSEcCtD
Meropenem—Diarrhoea—Thiotepa—sarcoma	0.00127	0.00127	CcSEcCtD
Meropenem—Body temperature increased—Mitoxantrone—sarcoma	0.00127	0.00127	CcSEcCtD
Meropenem—Abdominal pain—Mitoxantrone—sarcoma	0.00127	0.00127	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Meropenem—Diarrhoea—Dactinomycin—sarcoma	0.00126	0.00126	CcSEcCtD
Meropenem—Hypotension—Etoposide—sarcoma	0.00125	0.00125	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Meropenem—Dysuria—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Meropenem—Neutropenia—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Meropenem—Dizziness—Thiotepa—sarcoma	0.00123	0.00123	CcSEcCtD
Meropenem—Abdominal distension—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Meropenem—Asthma—Doxorubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Meropenem—Hypersensitivity—Vincristine—sarcoma	0.00122	0.00122	CcSEcCtD
Meropenem—Eosinophilia—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Meropenem—Paraesthesia—Etoposide—sarcoma	0.0012	0.0012	CcSEcCtD
Meropenem—Dyspnoea—Etoposide—sarcoma	0.00119	0.00119	CcSEcCtD
Meropenem—Somnolence—Etoposide—sarcoma	0.00119	0.00119	CcSEcCtD
Meropenem—Hypersensitivity—Mitoxantrone—sarcoma	0.00118	0.00118	CcSEcCtD
Meropenem—Asthenia—Vincristine—sarcoma	0.00118	0.00118	CcSEcCtD
Meropenem—Vomiting—Thiotepa—sarcoma	0.00118	0.00118	CcSEcCtD
Meropenem—Pneumonia—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Meropenem—Infestation NOS—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Meropenem—Infestation—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Meropenem—Vomiting—Dactinomycin—sarcoma	0.00118	0.00118	CcSEcCtD
Meropenem—Rash—Thiotepa—sarcoma	0.00117	0.00117	CcSEcCtD
Meropenem—Dermatitis—Thiotepa—sarcoma	0.00117	0.00117	CcSEcCtD
Meropenem—Headache—Thiotepa—sarcoma	0.00117	0.00117	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Meropenem—Rash—Dactinomycin—sarcoma	0.00117	0.00117	CcSEcCtD
Meropenem—Decreased appetite—Etoposide—sarcoma	0.00116	0.00116	CcSEcCtD
Meropenem—Renal failure—Epirubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Meropenem—Gastrointestinal disorder—Etoposide—sarcoma	0.00115	0.00115	CcSEcCtD
Meropenem—Asthenia—Mitoxantrone—sarcoma	0.00115	0.00115	CcSEcCtD
Meropenem—Neuropathy peripheral—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Meropenem—Jaundice—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Meropenem—Pain—Etoposide—sarcoma	0.00114	0.00114	CcSEcCtD
Meropenem—Constipation—Etoposide—sarcoma	0.00114	0.00114	CcSEcCtD
Meropenem—Dysuria—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Meropenem—Neutropenia—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Meropenem—Diarrhoea—Vincristine—sarcoma	0.00113	0.00113	CcSEcCtD
Meropenem—Sweating—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Meropenem—Hepatobiliary disease—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Meropenem—Epistaxis—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Meropenem—Nausea—Thiotepa—sarcoma	0.00111	0.00111	CcSEcCtD
Meropenem—Feeling abnormal—Etoposide—sarcoma	0.0011	0.0011	CcSEcCtD
Meropenem—Diarrhoea—Mitoxantrone—sarcoma	0.0011	0.0011	CcSEcCtD
Meropenem—Nausea—Dactinomycin—sarcoma	0.0011	0.0011	CcSEcCtD
Meropenem—Agranulocytosis—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Meropenem—Pneumonia—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Meropenem—Gastrointestinal pain—Etoposide—sarcoma	0.00109	0.00109	CcSEcCtD
Meropenem—Dizziness—Vincristine—sarcoma	0.00109	0.00109	CcSEcCtD
Meropenem—Infestation NOS—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Meropenem—Infestation—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Meropenem—Bradycardia—Epirubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Meropenem—Renal failure—Doxorubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Meropenem—Neuropathy peripheral—Doxorubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Meropenem—Urticaria—Etoposide—sarcoma	0.00106	0.00106	CcSEcCtD
Meropenem—Haemoglobin—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Meropenem—Jaundice—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Meropenem—Abdominal pain—Etoposide—sarcoma	0.00106	0.00106	CcSEcCtD
Meropenem—Body temperature increased—Etoposide—sarcoma	0.00106	0.00106	CcSEcCtD
Meropenem—Hepatitis—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Meropenem—Haemorrhage—Epirubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Meropenem—Vomiting—Vincristine—sarcoma	0.00105	0.00105	CcSEcCtD
Meropenem—Pharyngitis—Epirubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Meropenem—Sweating—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Meropenem—Rash—Vincristine—sarcoma	0.00104	0.00104	CcSEcCtD
Meropenem—Dermatitis—Vincristine—sarcoma	0.00104	0.00104	CcSEcCtD
Meropenem—Oedema peripheral—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Meropenem—Headache—Vincristine—sarcoma	0.00103	0.00103	CcSEcCtD
Meropenem—Hepatobiliary disease—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Meropenem—Epistaxis—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Meropenem—Vomiting—Mitoxantrone—sarcoma	0.00102	0.00102	CcSEcCtD
Meropenem—Agranulocytosis—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Meropenem—Rash—Mitoxantrone—sarcoma	0.00101	0.00101	CcSEcCtD
Meropenem—Dermatitis—Mitoxantrone—sarcoma	0.00101	0.00101	CcSEcCtD
Meropenem—Headache—Mitoxantrone—sarcoma	0.00101	0.00101	CcSEcCtD
Meropenem—Erythema multiforme—Epirubicin—sarcoma	0.000998	0.000998	CcSEcCtD
Meropenem—Bradycardia—Doxorubicin—sarcoma	0.000994	0.000994	CcSEcCtD
Meropenem—Hypersensitivity—Etoposide—sarcoma	0.000986	0.000986	CcSEcCtD
Meropenem—Haemoglobin—Doxorubicin—sarcoma	0.000982	0.000982	CcSEcCtD
Meropenem—Nausea—Vincristine—sarcoma	0.000981	0.000981	CcSEcCtD
Meropenem—Haemorrhage—Doxorubicin—sarcoma	0.000977	0.000977	CcSEcCtD
Meropenem—Hepatitis—Doxorubicin—sarcoma	0.000977	0.000977	CcSEcCtD
Meropenem—Pharyngitis—Doxorubicin—sarcoma	0.000969	0.000969	CcSEcCtD
Meropenem—Oedema peripheral—Doxorubicin—sarcoma	0.000962	0.000962	CcSEcCtD
Meropenem—Asthenia—Etoposide—sarcoma	0.00096	0.00096	CcSEcCtD
Meropenem—Nausea—Mitoxantrone—sarcoma	0.000955	0.000955	CcSEcCtD
Meropenem—Immune system disorder—Epirubicin—sarcoma	0.000953	0.000953	CcSEcCtD
Meropenem—Chills—Epirubicin—sarcoma	0.000947	0.000947	CcSEcCtD
Meropenem—Pruritus—Etoposide—sarcoma	0.000946	0.000946	CcSEcCtD
Meropenem—Erythema multiforme—Doxorubicin—sarcoma	0.000923	0.000923	CcSEcCtD
Meropenem—Erythema—Epirubicin—sarcoma	0.000919	0.000919	CcSEcCtD
Meropenem—Diarrhoea—Etoposide—sarcoma	0.000915	0.000915	CcSEcCtD
Meropenem—Flatulence—Epirubicin—sarcoma	0.000905	0.000905	CcSEcCtD
Meropenem—Tension—Epirubicin—sarcoma	0.000902	0.000902	CcSEcCtD
Meropenem—Dysgeusia—Epirubicin—sarcoma	0.0009	0.0009	CcSEcCtD
Meropenem—Nervousness—Epirubicin—sarcoma	0.000892	0.000892	CcSEcCtD
Meropenem—Back pain—Epirubicin—sarcoma	0.000889	0.000889	CcSEcCtD
Meropenem—Dizziness—Etoposide—sarcoma	0.000885	0.000885	CcSEcCtD
Meropenem—Immune system disorder—Doxorubicin—sarcoma	0.000882	0.000882	CcSEcCtD
Meropenem—Chills—Doxorubicin—sarcoma	0.000876	0.000876	CcSEcCtD
Meropenem—Vomiting—Etoposide—sarcoma	0.000851	0.000851	CcSEcCtD
Meropenem—Erythema—Doxorubicin—sarcoma	0.00085	0.00085	CcSEcCtD
Meropenem—Anaemia—Epirubicin—sarcoma	0.000849	0.000849	CcSEcCtD
Meropenem—Agitation—Epirubicin—sarcoma	0.000844	0.000844	CcSEcCtD
Meropenem—Rash—Etoposide—sarcoma	0.000843	0.000843	CcSEcCtD
Meropenem—Dermatitis—Etoposide—sarcoma	0.000843	0.000843	CcSEcCtD
Meropenem—Headache—Etoposide—sarcoma	0.000838	0.000838	CcSEcCtD
Meropenem—Flatulence—Doxorubicin—sarcoma	0.000838	0.000838	CcSEcCtD
Meropenem—Tension—Doxorubicin—sarcoma	0.000834	0.000834	CcSEcCtD
Meropenem—Dysgeusia—Doxorubicin—sarcoma	0.000833	0.000833	CcSEcCtD
Meropenem—Malaise—Epirubicin—sarcoma	0.000829	0.000829	CcSEcCtD
Meropenem—Nervousness—Doxorubicin—sarcoma	0.000826	0.000826	CcSEcCtD
Meropenem—Syncope—Epirubicin—sarcoma	0.000824	0.000824	CcSEcCtD
Meropenem—Leukopenia—Epirubicin—sarcoma	0.000822	0.000822	CcSEcCtD
Meropenem—Back pain—Doxorubicin—sarcoma	0.000822	0.000822	CcSEcCtD
Meropenem—Loss of consciousness—Epirubicin—sarcoma	0.000808	0.000808	CcSEcCtD
Meropenem—Cough—Epirubicin—sarcoma	0.000802	0.000802	CcSEcCtD
Meropenem—Nausea—Etoposide—sarcoma	0.000795	0.000795	CcSEcCtD
Meropenem—Hypertension—Epirubicin—sarcoma	0.000793	0.000793	CcSEcCtD
Meropenem—Anaemia—Doxorubicin—sarcoma	0.000786	0.000786	CcSEcCtD
Meropenem—Chest pain—Epirubicin—sarcoma	0.000782	0.000782	CcSEcCtD
Meropenem—Agitation—Doxorubicin—sarcoma	0.000781	0.000781	CcSEcCtD
Meropenem—Anxiety—Epirubicin—sarcoma	0.00078	0.00078	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000777	0.000777	CcSEcCtD
Meropenem—Malaise—Doxorubicin—sarcoma	0.000767	0.000767	CcSEcCtD
Meropenem—Syncope—Doxorubicin—sarcoma	0.000762	0.000762	CcSEcCtD
Meropenem—Leukopenia—Doxorubicin—sarcoma	0.000761	0.000761	CcSEcCtD
Meropenem—Confusional state—Epirubicin—sarcoma	0.000756	0.000756	CcSEcCtD
Meropenem—Anaphylactic shock—Epirubicin—sarcoma	0.00075	0.00075	CcSEcCtD
Meropenem—Oedema—Epirubicin—sarcoma	0.00075	0.00075	CcSEcCtD
Meropenem—Loss of consciousness—Doxorubicin—sarcoma	0.000747	0.000747	CcSEcCtD
Meropenem—Infection—Epirubicin—sarcoma	0.000745	0.000745	CcSEcCtD
Meropenem—Cough—Doxorubicin—sarcoma	0.000742	0.000742	CcSEcCtD
Meropenem—Shock—Epirubicin—sarcoma	0.000738	0.000738	CcSEcCtD
Meropenem—Nervous system disorder—Epirubicin—sarcoma	0.000735	0.000735	CcSEcCtD
Meropenem—Thrombocytopenia—Epirubicin—sarcoma	0.000734	0.000734	CcSEcCtD
Meropenem—Hypertension—Doxorubicin—sarcoma	0.000734	0.000734	CcSEcCtD
Meropenem—Tachycardia—Epirubicin—sarcoma	0.000732	0.000732	CcSEcCtD
Meropenem—Skin disorder—Epirubicin—sarcoma	0.000728	0.000728	CcSEcCtD
Meropenem—Hyperhidrosis—Epirubicin—sarcoma	0.000725	0.000725	CcSEcCtD
Meropenem—Chest pain—Doxorubicin—sarcoma	0.000724	0.000724	CcSEcCtD
Meropenem—Anxiety—Doxorubicin—sarcoma	0.000721	0.000721	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000719	0.000719	CcSEcCtD
Meropenem—Anorexia—Epirubicin—sarcoma	0.000715	0.000715	CcSEcCtD
Meropenem—Hypotension—Epirubicin—sarcoma	0.000701	0.000701	CcSEcCtD
Meropenem—Confusional state—Doxorubicin—sarcoma	0.0007	0.0007	CcSEcCtD
Meropenem—Anaphylactic shock—Doxorubicin—sarcoma	0.000694	0.000694	CcSEcCtD
Meropenem—Oedema—Doxorubicin—sarcoma	0.000694	0.000694	CcSEcCtD
Meropenem—Infection—Doxorubicin—sarcoma	0.000689	0.000689	CcSEcCtD
Meropenem—Shock—Doxorubicin—sarcoma	0.000683	0.000683	CcSEcCtD
Meropenem—Nervous system disorder—Doxorubicin—sarcoma	0.00068	0.00068	CcSEcCtD
Meropenem—Thrombocytopenia—Doxorubicin—sarcoma	0.000679	0.000679	CcSEcCtD
Meropenem—Insomnia—Epirubicin—sarcoma	0.000678	0.000678	CcSEcCtD
Meropenem—Tachycardia—Doxorubicin—sarcoma	0.000677	0.000677	CcSEcCtD
Meropenem—Skin disorder—Doxorubicin—sarcoma	0.000674	0.000674	CcSEcCtD
Meropenem—Paraesthesia—Epirubicin—sarcoma	0.000673	0.000673	CcSEcCtD
Meropenem—Hyperhidrosis—Doxorubicin—sarcoma	0.000671	0.000671	CcSEcCtD
Meropenem—Dyspnoea—Epirubicin—sarcoma	0.000669	0.000669	CcSEcCtD
Meropenem—Somnolence—Epirubicin—sarcoma	0.000667	0.000667	CcSEcCtD
Meropenem—Anorexia—Doxorubicin—sarcoma	0.000661	0.000661	CcSEcCtD
Meropenem—Dyspepsia—Epirubicin—sarcoma	0.00066	0.00066	CcSEcCtD
Meropenem—Decreased appetite—Epirubicin—sarcoma	0.000652	0.000652	CcSEcCtD
Meropenem—Hypotension—Doxorubicin—sarcoma	0.000648	0.000648	CcSEcCtD
Meropenem—Gastrointestinal disorder—Epirubicin—sarcoma	0.000647	0.000647	CcSEcCtD
Meropenem—Pain—Epirubicin—sarcoma	0.000641	0.000641	CcSEcCtD
Meropenem—Constipation—Epirubicin—sarcoma	0.000641	0.000641	CcSEcCtD
Meropenem—Insomnia—Doxorubicin—sarcoma	0.000628	0.000628	CcSEcCtD
Meropenem—Paraesthesia—Doxorubicin—sarcoma	0.000623	0.000623	CcSEcCtD
Meropenem—Dyspnoea—Doxorubicin—sarcoma	0.000619	0.000619	CcSEcCtD
Meropenem—Feeling abnormal—Epirubicin—sarcoma	0.000618	0.000618	CcSEcCtD
Meropenem—Somnolence—Doxorubicin—sarcoma	0.000617	0.000617	CcSEcCtD
Meropenem—Gastrointestinal pain—Epirubicin—sarcoma	0.000613	0.000613	CcSEcCtD
Meropenem—Dyspepsia—Doxorubicin—sarcoma	0.000611	0.000611	CcSEcCtD
Meropenem—Decreased appetite—Doxorubicin—sarcoma	0.000603	0.000603	CcSEcCtD
Meropenem—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000599	0.000599	CcSEcCtD
Meropenem—Urticaria—Epirubicin—sarcoma	0.000596	0.000596	CcSEcCtD
Meropenem—Pain—Doxorubicin—sarcoma	0.000593	0.000593	CcSEcCtD
Meropenem—Constipation—Doxorubicin—sarcoma	0.000593	0.000593	CcSEcCtD
Meropenem—Abdominal pain—Epirubicin—sarcoma	0.000593	0.000593	CcSEcCtD
Meropenem—Body temperature increased—Epirubicin—sarcoma	0.000593	0.000593	CcSEcCtD
Meropenem—Feeling abnormal—Doxorubicin—sarcoma	0.000572	0.000572	CcSEcCtD
Meropenem—Gastrointestinal pain—Doxorubicin—sarcoma	0.000567	0.000567	CcSEcCtD
Meropenem—Hypersensitivity—Epirubicin—sarcoma	0.000552	0.000552	CcSEcCtD
Meropenem—Urticaria—Doxorubicin—sarcoma	0.000551	0.000551	CcSEcCtD
Meropenem—Body temperature increased—Doxorubicin—sarcoma	0.000548	0.000548	CcSEcCtD
Meropenem—Abdominal pain—Doxorubicin—sarcoma	0.000548	0.000548	CcSEcCtD
Meropenem—Asthenia—Epirubicin—sarcoma	0.000538	0.000538	CcSEcCtD
Meropenem—Pruritus—Epirubicin—sarcoma	0.000531	0.000531	CcSEcCtD
Meropenem—Diarrhoea—Epirubicin—sarcoma	0.000513	0.000513	CcSEcCtD
Meropenem—Hypersensitivity—Doxorubicin—sarcoma	0.000511	0.000511	CcSEcCtD
Meropenem—Asthenia—Doxorubicin—sarcoma	0.000498	0.000498	CcSEcCtD
Meropenem—Dizziness—Epirubicin—sarcoma	0.000496	0.000496	CcSEcCtD
Meropenem—Pruritus—Doxorubicin—sarcoma	0.000491	0.000491	CcSEcCtD
Meropenem—Vomiting—Epirubicin—sarcoma	0.000477	0.000477	CcSEcCtD
Meropenem—Diarrhoea—Doxorubicin—sarcoma	0.000475	0.000475	CcSEcCtD
Meropenem—Rash—Epirubicin—sarcoma	0.000473	0.000473	CcSEcCtD
Meropenem—Dermatitis—Epirubicin—sarcoma	0.000472	0.000472	CcSEcCtD
Meropenem—Headache—Epirubicin—sarcoma	0.00047	0.00047	CcSEcCtD
Meropenem—Dizziness—Doxorubicin—sarcoma	0.000459	0.000459	CcSEcCtD
Meropenem—Nausea—Epirubicin—sarcoma	0.000445	0.000445	CcSEcCtD
Meropenem—Vomiting—Doxorubicin—sarcoma	0.000441	0.000441	CcSEcCtD
Meropenem—Rash—Doxorubicin—sarcoma	0.000437	0.000437	CcSEcCtD
Meropenem—Dermatitis—Doxorubicin—sarcoma	0.000437	0.000437	CcSEcCtD
Meropenem—Headache—Doxorubicin—sarcoma	0.000435	0.000435	CcSEcCtD
Meropenem—Nausea—Doxorubicin—sarcoma	0.000412	0.000412	CcSEcCtD
